Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Andrew D. Weinberg|Nature Communications|2021Cited by 154
PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumorsRebekka Duhen, Thomas Duhen|Journal of Clinical Investigation|2022Cited by 70